Skip to main content
Fig. 8 | BMC Developmental Biology

Fig. 8

From: Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells

Fig. 8

Immunosuppressive activity of tissue-specific hMSCs in allogeneic condition after pre and post-preconditioning with Dex; a and c The bar graph represents that 48 h Dex-pretreated BM-MSCs and AD-MSCs shows the significant ability to inhibit the PBMCs proliferation with respect to activated PBMCs, b and d the bar graph represents that 48 h Dex-pretreated DP-MSCs and UC-MSCs shows significant inhibition compared to untreated hMSCs and activated hMSCs. Data from three donors in duplicates and shown as mean ± SD; ***p < 0.001, **p < 0.01, *p < 0.05. Note: PBMCs* (PHA activated PBMCs)

Back to article page